Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Vitamin D3 and Improved Metabolic Parameters

Time to effect

Median: 3.7 months · IQR 3.7 months–3.7 months · Range 3.7 months–3.7 months — Reported in 1 of 1 study

1 of 1 paper

Unveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients.
- 2025-03-07
- RCT · n = 163
- Journal of translational medicine 23(1)
- - Huai Heng Loh
  - Siow Phing Tay
  - Ai Jiun Koa
  - Mei Ching Yong
  - Asri Said
  - Chee Shee Chai
  - Natasya Marliana Abdul Malik
  - Anselm Ting Su
  - Bonnie Bao Chee Tang
  - Florence Hui Sieng Tan
  - Norlela Sukor
- PubMed: 40055713
- DOI: 10.1186/s12967-025-06312-w
18 Insights on
- Improved Metabolic Parameters
- High evidence
- Large Human Trial
- Clinical
The combination of vitamin D3 and Dapagliflozin treatment led to significant improvements in metabolic parameters and nocturnal heart rates
Effect
Beneficial
Effect size
Moderate
Significant
Yes